Umed Clinical Trials Sp. z o.o.

Lodz 26 trials 17 recruiting

26 Registered trials

17 Currently recruiting

Organisation

Umed Clinical Trials Sp. z o.o.

Location

Lodz, Poland

Identifier

ORG-100049523

Address

Bud A-2, Ul. Pomorska 251, 92-213, Poland

Departments

-
Cardiology
Department of Pediatrics, Diabetology, Endocrinology & Nephrology
Klinika Onkologii Klinicznej
N/A
NA
Oddział Nefrologii,Hipertensjologii i Transplantologii Nerek
UMED Clinical Trials
Umed Clinical Trials Ambulatorium
UMED CLINICAL TRIALS Sp. z o.o., ul. Pomorska 251 budynek A-2

Clinical trials at this site (26)

Search interface

A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma Recruiting

2025-523180-38-00 Uncontrolled Moderate to Severe Eosinophilic Asthma 4 2026-05-21
A Long-term Study of Navenibart in Participants with Hereditary Angioedema Recruiting

2025-521142-22-00 Hereditary Angioedema 5 2026-03-27
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRES… Recruiting

2025-522170-36-00 Diabetes Mellitus, Type 1 5 2026-02-03
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Hereditary Angioedema 5 2026-01-16
A Phase 2 Study of Lesigercept (YH35324) in Adult Patients with Chronic Spontaneous Urticaria (CLEAR) Recruiting

2025-524006-14-00 Chronic Spontaneous Urticaria 4 2026-04-20
A trial to learn how safe the combination of rilvegostomig and chemotherapy is and how well it works compared to durvalumab and chemotherapy… Recruiting

2025-523085-24-00 Biliary Tract Cancer 5 2026-04-13
A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diab… Recruiting

2024-519494-19-00 Nutritional and metabolic diseases 5 2025-12-22
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting

2025-520473-40-00 Moderate to Very Severe Chronic Obstructive Pulmonary D 4 2025-09-29
A study of Navenibart in Participants with Hereditary Angioedema Recruiting

2025-521660-35-00 Hereditary Angioedema 5 2025-09-11
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme… Recruiting

2023-508875-35-00 Heart condition 5 2025-09-01
Clinical study to evaluate the safety of investigational medicinal product called AD-O51.4 in patients with advanced malignancies Recruiting

2024-515687-31-01 Patients suffering from cancer without further treatmen 1 2025-07-09
A study to understand if sotagliflozin improves symptoms and is safe in people with hypertrophic cardiomyopathy Recruiting

2024-513869-39-00 Obstructive Cardiomyopathy, Hypertrophic 5 2025-06-27
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 6 2024-05-30
Frexalimab in preservation of endogenous insulin secretion compared to placebo in adults, adolescents and children on top of Insulin therapy… Recruiting

2022-500531-36-00 Type 1 diabetes mellitus 4 2024-02-02
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended

2024-513210-36-00 Chronic Spontaneous Urticaria 5 2025-04-04
STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended

2023-508055-40-00 Obesity 6 2025-02-18
A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC Ended

2023-504753-12-00 Lung Cancer, Non-Small Cell 5 2024-10-01
A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed … Ended

2022-502746-27-00 Endometrial Cancer 5 2020-08-21
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis Ended

2023-506655-19-00 Ulcerative Colitis (UC) 4 2024-05-16
MYK-224 in Heart Failure with Preserved Ejection Fraction (HFpEF) Ended

2023-505919-21-00 Heart failure with preserved ejection fraction (HFpEF) 4 2024-04-25